These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 9107180)

  • 1. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
    Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
    Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kallikrein-kinin system in post-myocardial infarction cardiac remodeling.
    Wollert KC; Drexler H
    Am J Cardiol; 1997 Aug; 80(3A):158A-161A. PubMed ID: 9293971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
    Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
    J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II.
    Stauss HM; Zhu YC; Redlich T; Adamiak D; Mott A; Kregel KC; Unger T
    J Cardiovasc Risk; 1994 Oct; 1(3):255-62. PubMed ID: 7621306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
    Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats.
    Taylor K; Patten RD; Smith JJ; Aronovitz MJ; Wight J; Salomon RN; Konstam MA
    J Cardiovasc Pharmacol; 1998 May; 31(5):654-60. PubMed ID: 9593063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy.
    Zhu YC; Zhu YZ; Gohlke P; Stauss HM; Unger T
    Am J Cardiol; 1997 Aug; 80(3A):110A-117A. PubMed ID: 9293963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
    Linz W; Wiemer G; Schölkens BA
    Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
    Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A
    Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the vasopeptidase inhibitor omapatrilat on cardiac endogenous kinins in rats with acute myocardial infarction.
    Blais C; Lapointe N; Rouleau JL; Clément R; Gervais N; Geadah D; Adam A
    Peptides; 2001 Jun; 22(6):953-62. PubMed ID: 11390026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice.
    Yang XP; Liu YH; Mehta D; Cavasin MA; Shesely E; Xu J; Liu F; Carretero OA
    Circ Res; 2001 May; 88(10):1072-9. PubMed ID: 11375278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat.
    Rumble JR; Komers R; Cooper ME
    J Hypertens; 1996 May; 14(5):601-7. PubMed ID: 8762203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.
    Benetos A; Levy BI; Lacolley P; Taillard F; Duriez M; Safar ME
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3196-201. PubMed ID: 9409311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats.
    Liu YH; Yang XP; Mehta D; Bulagannawar M; Scicli GM; Carretero OA
    Am J Physiol Heart Circ Physiol; 2000 Feb; 278(2):H507-14. PubMed ID: 10666082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats.
    Gohlke P; Kuwer I; Schnell A; Amann K; Mall G; Unger T
    Hypertension; 1997 Jan; 29(1 Pt 2):478-82. PubMed ID: 9039145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of endogenous kinins, prostanoids, and NO on kinin B1 and B2 receptor expression in the rabbit.
    Marceau F; Larrivée JF; Bouthillier J; Bachvarova M; Houle S; Bachvarov DR
    Am J Physiol; 1999 Dec; 277(6):R1568-78. PubMed ID: 10600901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ACE inhibition or AT1 blockade in the remodeling following myocardial infarction.
    Holtz J
    Basic Res Cardiol; 1998; 93 Suppl 2():92-100. PubMed ID: 9833170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of bradykinin on myocardial energy metabolism and infarct size.
    Linz W; Wiemer G; Schölkens BA
    Am J Cardiol; 1997 Aug; 80(3A):118A-123A. PubMed ID: 9293964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
    Komers R; Cooper ME
    Am J Physiol; 1995 Apr; 268(4 Pt 2):F588-94. PubMed ID: 7733315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.